This is a snippet of the transcript, sign up to read more.
Good question. The answer is very hard. I don’t know what the number is now, post-Linear Technology acquisition and Maxim, but when we were just Analog, we had a 52% market share on the A-to-D and D-to-A markets. When we move customers, we’d usually go up against Texas Instruments; sometimes, Linear Tech was the higher-priced, more niche player in the converter space. But with things like resolution, jitter, and true resolution, TI has a huge marketing machine behind them. They would market and advertise converter chips with a higher resolution, but that doesn’t mean a lot to an engineer. It’s how true the resolution is. You could be 24 bits but are you really only accurate for this application up to 14 bits? We were always known as the conservative company, and if we said it was X resolution, it was X resolution. Apologies for the analogy here, it's not the best, but it's the only one I can think of. BMW always understates its horsepower rating; it's kind of like that. So, it’s very difficult because many factors make a good A-to-D good; you’ve got jitter, noise, signal-to-noise ratio, resolution, cost, size, and channels. There is a lot to it, and there are a lot of different permutations.
This is a snippet of the transcript, sign up to read more.
That’s also a complicated answer. I’m not going to be able to explain it fully; we have specialist engineers for this, and they often have to refer to certain other subject matter experts for certain use cases. So you're specialized, and if one analog-to-digital converter specialist can't answer a question, the other can because of a certain use case. The simplified answer is always to look at it from the lens of, I'm receiving an analog signal; the world is analog. There's an infinite amount of sampling you could do. Let's say you have one second of audio. Because it's analog, there's no discreet start/stop. Digital only operates in discreet. There are certain complexities, like measuring the impedance of blood glucose and how it changes under specific temperature and resistance measurements, and there's a huge variation. It's easy to get it wrong because your measuring is so small. In this case, you're measuring the smallest amount of impedance changes for the blood glucose strip.
This is a snippet of the transcript, sign up to read more.
That was a tough one for me. I had dinner a couple of weeks ago with some old teammates who expressed a lot of discontent with that whole thing. It's a peculiar decision for a lot of us. What I think happened was that there are very few broad-market semiconductor companies; broad market is a requirement. We're not buying, no matter how valuable they are, NVIDIA is too big, and ADI would have no idea what to do with that technology. Very few other companies are big enough to be attractive and small enough to be acquired that are even somewhat complementary to your portfolio. There’s a lot of overlap, in both good and bad ways. The team was even expressing that to me recently. I think Vince bought a book of business, and semiconductor wins are very sticky. You could shut the lights off and stop answering customer phone calls tomorrow, and you'd still have a long tail of revenue stream coming because many designs last 10, 15, 20 years, if not longer. That was another advantage to ADI, by the way.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research